Neal H Shorstein1, William G Myers. 1. Departments of Ophthalmology and Quality, Shorstein - Kaiser Permanente, Oakland, California; Department of Ophthalmology, Myers - Northwestern University, Chicago, IL.
Abstract
PURPOSE OF REVIEW: Routine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence. RECENT FINDINGS: Adoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved. SUMMARY: Intraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues.
PURPOSE OF REVIEW: Routine prophylaxis for adverse events following cataract surgery is evolving. Prior reliance on topical eyedrop instillation by patients is giving way to surgeon directed injections at the time of cataract surgery. The benefit of this new approach is assured delivery of drugs in standardized doses which should optimize the healing process and reduce the incidence of untoward events with higher confidence. RECENT FINDINGS: Adoption rates of intracameral antibiotic injection amongst European and American cataract surgeons is increasing. Techniques to inject periocular corticosteroid for routine inflammation prophylaxis are also in development. In combination with intraoperative pharmacologic dilation, a drop-free modality can be achieved. SUMMARY: Intraoperative injections offer the patient and surgeon assured drug delivery and hold promise to avoid the pitfalls of patient adherence, incorrect topical instillation, and topical drop-associated corneal issues.
Authors: Ramón Lorente; Victoria de Rojas; Paula Vázquez de Parga; Claudio Moreno; Juan Varela; Maria Luisa Landaluce; Julia Méndez; Betty Lorente Journal: Ophthalmology Date: 2012-06-17 Impact factor: 12.079
Authors: Fernando Paganelli; José A Cardillo; Luiz A S Melo; Anselmo G Oliveira; Mirian Skaf; Rogério A Costa Journal: Ophthalmology Date: 2004-11 Impact factor: 12.079
Authors: Syd L Tyson; Shamik Bafna; Joseph P Gira; Damien F Goldberg; Jason J Jones; Michael P Jones; Janet K Kim; Joseph M Martel; Michael L Nordlund; Ian K Piovanetti-Perez; Inder Paul Singh; Jamie Lynne Metzinger; Deepa Mulani; Swati Sane; Jonathan H Talamo; Michael H Goldstein Journal: J Cataract Refract Surg Date: 2018-10-24 Impact factor: 3.351
Authors: Sydney L Tyson; Robert Bailey; Janika S Roman; Tingting Zhan; Lisa A Hark; Julia A Haller Journal: Curr Opin Ophthalmol Date: 2017-01 Impact factor: 3.761